An Opened, Non-controlled, Multi-center Study of M118102 in Subjects with Asteatosis
- Conditions
- Asteatosis
- Registration Number
- JPRN-jRCT1080223223
- Lead Sponsor
- Maruho Co.,Ltd.
- Brief Summary
The efficacy of M118102 was confirmed as the effects of the soft ointment were maintained after switched to M118102. There were no safety issues associated with M118102.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- completed
- Sex
- All
- Target Recruitment
- 60
Asteatosis Patients
(1) Patients with a history of any of the following:
1) Serious allergy (shock, anaphylactic symptoms)
2) Allergy to heparinoid
3) Cutaneous hypersensitivity to topical medicines (such as contact dermatitis)
4) Hemorrhagic blood disorder (hemophilia , thrombocytopenia , purpura )
(2) Patients with the following concurrent diseases:
1) Patients with any disorders that should not be enrolled in the sutdy such as;
-severe cardiac disorders
-severe hepatic disorders
-severe pulmonary disorders
-severe gastrointestinal disorders
-severe blood disorders
2) Supervening skin disease on Asteatosis
3) Hemorrhagic blood disorder (hemophilia , thrombocytopenia , purpura )
(3) Pregnant women, women who may be pregnant, lactating women or women who wish to become pregnant or women who are unwilling to use a suitable method of contraception as directed by the principal investigator or sub-investigator.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method